Global Therapeutic Monoclonal Antibodies Drug Market to Reach USD 415.5 Billion by 2032, Exhibiting a CAGR of 11.0% Global therapeutic monoclonal antibodies drug market size was valued at USD 175.3 billion in 2024. The market is projected to grow from USD 195.1 billion in 2025 to USD 415.5 billion by 2032, exhibiting a CAGR of 11.0% during the forecast period. The market's robust growth is largely attributed to the increasing prevalence of chronic diseases, rising adoption of targeted therapies, and significant advancements in biotechnology, particularly in oncology, autoimmune disorders, and infectious diseases. Get Full Report Here: https://www.24chemicalresearch.com/reports/283234/global-therapeutic-monoclonal-antibodies-drug-market